Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Treasury Shares: 2023-2024

  • CorMedix's Treasury Shares was N/A to $291,494 in Q4 2024 from the same period last year, while for Dec 2024 it was $291,494, marking a year-over-year change of. This contributed to the annual value of $291,494 for FY2024, which is N/A change from last year.
  • According to the latest figures from Q4 2024, CorMedix's Treasury Shares is $291,494, which was up 181.00% from $103,735 recorded in Q3 2023.
  • CorMedix's Treasury Shares' 5-year high stood at $291,494 during Q4 2024, with a 5-year trough of $103,735 in Q3 2023.
  • Moreover, its 2-year median value for Treasury Shares was $197,614 (2023), whereas its average is $197,614.